Table 3. Provider-identified facilitators, challenges for providers, and barriers for patients in provision of/access to treatment for hrHPV+ patients (n = 16).
| Facilitator, challenge, or barrier | Providers selecting this option as most important (n, %) |
|---|---|
| Facilitators of treatment | |
| No cost for treatment | 8 (50%) |
| Counseling from community health volunteers | 3 (19%) |
| Understanding of where/how to get treatment | 3 (19%) |
| Accessibility of treatment sites | 1 (6%) |
| Efficiency of treatment visits | 1 (6%) |
| Challenges in providing cryotherapy | |
| Workload from other patients | 6 (40%) |
| Cryotherapy machine or gas broken/unavailable | 5 (33%) |
| Not enough providers | 3 (20%) |
| Inadequate training for providers | 1 (7%) |
| Barriers hrHPV+ women face in deciding to get treated | |
| Lack of participant knowledge of hrHPV and cervical cancer | 10 (67%) |
| Partner not supportive | 2 (13%) |
| Family not supportive | 2 (13%) |
| Disbelief in the need for treatment | 1 (7%) |
| Barriers hrHPV+ women face in accessing treatment once they have decided to get it | |
| Financial barriers | 7 (47%) |
| Partner not supportive | 3 (20%) |
| Family not supportive | 2 (13%) |
| Lack of transportation | 2 (13%) |
| Distance to treatment site | 1 (7%) |
Abbreviations: hrHPV = high-risk human papillomavirus